HK Stock Market Move | BRAINAURORA-B (06681) rose by over 13% and signed a strategic cooperation agreement with Silk Road to enter the Malaysian market.
Brain Dynamics Aurora-B (06681) rose more than 13%, as of the time of publication, it increased by 13.36%, reaching 4.92 Hong Kong dollars, with a turnover of 4.86 billion Hong Kong dollars.
BRAIN AURORA-B (06681) rose by more than 13%, as of the deadline, it rose by 13.36%, reaching 4.92 Hong Kong dollars, with a turnover of 486 million Hong Kong dollars.
On the news front, BrainAurora announced at noon that the company has entered into a strategic cooperation agreement with Silicon Valley Technology Co., Ltd. (Silicon Valley), and the two parties will deepen their strategic cooperation in areas such as localized landing, market promotion, and research commercialization of cognitive impairment digital therapy products in Malaysia and Southeast Asia, jointly promoting the development of the digital health industry.
The board believes that the cooperation with Silicon Valley Technology Co., Ltd. marks the company's official entry into the Malaysian market, further expanding its business network in Southeast Asia. This cooperation will help systematically export the digital therapy experience and technical system verified in the Chinese market to regional markets with growth potential and policy support, further expanding the company's brand influence and business coverage internationally and enhancing its global influence.
Related Articles

Harbin Pharmaceutical Group (600664.SH): Ferrous Protein Succinate obtains approval notice for chemical raw materials drug market application.

Orient: Opportunities for mid- to high-end positioning in household appliances are emerging. We recommend operating leading companies with stable management.

Goldman Sachs: Asia-Pacific confident in the buy list (select version) adding MAO GEPING (01318) and removing CHINA RES LAND (01109)
Harbin Pharmaceutical Group (600664.SH): Ferrous Protein Succinate obtains approval notice for chemical raw materials drug market application.

Orient: Opportunities for mid- to high-end positioning in household appliances are emerging. We recommend operating leading companies with stable management.

Goldman Sachs: Asia-Pacific confident in the buy list (select version) adding MAO GEPING (01318) and removing CHINA RES LAND (01109)






